ENDRA LIFE SCIENCES INC (NDRA)

US29273B3024 - Common Stock

5.36  -0.24 (-4.29%)

ENDRA LIFE SCIENCES INC

NASDAQ:NDRA (12/24/2024, 1:14:23 PM)

5.36

-0.24 (-4.29%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS SubIndustryHealth Care Equipment
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%52.3%
Sales Q2Q%N/A
CRS2.7
6 Month-96.7%
Overview
Earnings (Last)11-15 2024-11-15/bmo
Earnings (Next)N/A N/A
Ins Owners0.02%
Inst Owners0.09%
Market Cap2.89M
Shares540.00K
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts82.86
Short Float %N/A
Short Ratio0.01
IPO06-28 2017-06-28
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

NDRA Daily chart

Company Profile

ENDRA Life Sciences Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Ann Arbor, Michigan and currently employs 21 full-time employees. The company went IPO on 2017-06-28. ENDRA Life Sciences Inc. is developing an enhanced ultrasound technology platform - Thermo Acoustic Enhanced Ultrasound (TAEUS), a technology which characterizes tissue similar to a magnetic resonance imaging (MRI). The firm's TAEUS technology uses radio frequency (RF) pulses to stimulate tissues, using a small fraction (less than 1%) of the amount of energy that would be transmitted into the body during an MRI scan. The use of RF energy allows its TAEUS technology to penetrate deep into tissue, enabling the imaging of human anatomy at depths equivalent to those of conventional ultrasound. The RF pulses are absorbed by tissue and converted into ultrasound signals. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease (SLD), a chronic liver disease spectrum. The company is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Company Info

ENDRA LIFE SCIENCES INC

3600 Green Ct Ste 350

Ann Arbor MICHIGAN 48105

P: 17343350468

CEO: Francois Michelon

Employees: 21

Website: https://www.endrainc.com/